IMA vs RUN · rev $9.2M vs P/E 6.0, rev $2.04B
ImageneBio, Inc. (IMA) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
ImageneBio, Inc. (IMA) is a biotechnology company listed on NASDAQ.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported IMA revenue for 2023-12-31 was $9.2M. Net income was -$68.2M. Revenue was down 41.3% from 2022-12-31 to 2023-12-31. IMA currently screens at market cap $64.7M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
IMA currently screens at market cap $64.7M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the IMA and RUN stock pages for the full models.
Not investment advice.